Meinberger, D.; Drexelius, M.G.; Grabeck, J.; Hermes, G.; Roth, A.; Elezagic, D.; Neundorf, I.; Streichert, T.; Klatt, A.R.
Modified CLEC3A-Derived Antimicrobial Peptides Lead to Enhanced Antimicrobial Activity against Drug-Resistant Bacteria. Antibiotics 2023, 12, 1532.
https://doi.org/10.3390/antibiotics12101532
AMA Style
Meinberger D, Drexelius MG, Grabeck J, Hermes G, Roth A, Elezagic D, Neundorf I, Streichert T, Klatt AR.
Modified CLEC3A-Derived Antimicrobial Peptides Lead to Enhanced Antimicrobial Activity against Drug-Resistant Bacteria. Antibiotics. 2023; 12(10):1532.
https://doi.org/10.3390/antibiotics12101532
Chicago/Turabian Style
Meinberger, Denise, Marco G. Drexelius, Joshua Grabeck, Gabriele Hermes, Annika Roth, Dzemal Elezagic, Ines Neundorf, Thomas Streichert, and Andreas R. Klatt.
2023. "Modified CLEC3A-Derived Antimicrobial Peptides Lead to Enhanced Antimicrobial Activity against Drug-Resistant Bacteria" Antibiotics 12, no. 10: 1532.
https://doi.org/10.3390/antibiotics12101532
APA Style
Meinberger, D., Drexelius, M. G., Grabeck, J., Hermes, G., Roth, A., Elezagic, D., Neundorf, I., Streichert, T., & Klatt, A. R.
(2023). Modified CLEC3A-Derived Antimicrobial Peptides Lead to Enhanced Antimicrobial Activity against Drug-Resistant Bacteria. Antibiotics, 12(10), 1532.
https://doi.org/10.3390/antibiotics12101532